Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Supportive care.

John R Wingard1, W Garrett Nichols, George B McDonald

  • 1University of Florida, Gainesville, FL 32610-3001, USA.

Hematology. American Society of Hematology. Education Program
|November 25, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to: "Liberalized Diets During Neutropenia: Ongoing Uncertainty in Hematopoietic Stem-Cell Transplantation" and "Impact of Transplant Type on Infection Risk in Studies of Neutropenic Diets".

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trial.

The Lancet. Oncology·2026
Same author

Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute Leukemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Respiratory Virus Infections and Pulmonary Impairment After Allogeneic Hematopoietic Cell Transplantation.

The Journal of infectious diseases·2025
Same author

Soluble B-cell maturation antigen as a serum marker of MRD in patients with multiple myeloma.

Frontiers in oncology·2025
Same author

Case Report: Reactive T-cell large granular lymphocytes in the bone marrow of a patient with relapsed/refractory multiple myeloma receiving teclistamab.

Frontiers in oncology·2025
Same journal

Nze C, Flowers CR. Barriers to accessing cellular therapy for patients receiving care in community practices. Hematology Am Soc Hematol Educ Program. 2023;2023(1):382-385.

Hematology. American Society of Hematology. Education Program·2025
Same journal

CAR T-cell therapy and bispecific antibodies in the management of multiple myeloma.

Hematology. American Society of Hematology. Education Program·2025
Same journal

Emerging immunotherapy advances for non-Hodgkin lymphomas: engaging T cells in the fight.

Hematology. American Society of Hematology. Education Program·2025
Same journal

Anticoagulants in hematologic malignancies: what is the data?

Hematology. American Society of Hematology. Education Program·2025
Same journal

Diagnosis and management of cold agglutinin disease.

Hematology. American Society of Hematology. Education Program·2025
Same journal

What to know about rare B-cell malignancies in 2025.

Hematology. American Society of Hematology. Education Program·2025
See all related articles

Minimizing complications like infections and liver damage is crucial for treating hematologic malignancies. This chapter reviews fungal infections, respiratory viral infections, and sinusoidal obstruction syndrome, offering insights into prevention and treatment strategies.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Hepatology

Background:

  • Hematologic malignancies require complex treatments with significant risks.
  • Myelosuppression and immunosuppression increase susceptibility to severe infections.
  • Organ damage, particularly hepatic sinusoidal injury, is a major concern.

Purpose of the Study:

  • To provide a comprehensive overview of key complications in hematologic malignancy treatment.
  • To discuss recent advancements in understanding and managing invasive fungal infections.
  • To review the epidemiology and management of respiratory viral infections and sinusoidal obstruction syndrome.

Main Methods:

  • Review of current literature on invasive fungal infections (Candida, Aspergillus).
  • Analysis of community-acquired respiratory virus (CRV) epidemiology in immunocompromised patients.

Related Experiment Videos

  • Examination of pathogenesis, diagnosis, and management of sinusoidal obstruction syndrome.

    • Main Results:

    • Fungal and viral infections pose life-threatening risks, necessitating effective prophylaxis and treatment.
    • Understanding CRV epidemiology aids in risk stratification and clinical management.
    • New insights into sinusoidal obstruction syndrome pathogenesis inform prevention and treatment.

    Conclusions:

    • Optimizing treatment outcomes involves proactive management of infectious complications and organ toxicities.
    • Multifaceted strategies including diagnostics, combination therapies, and host immunity support are essential.
    • Integrated approaches to managing fungal infections, viral infections, and hepatic injury are critical for patient survival.